Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Karpouzas, George A.Szekanecz, ZoltánBaecklund, EvaMikuls, Ted R.Bhatt, Deepak L.Wang, CunshanSawyerr, Gosford A.Chen, YanMenon, SujathaConnell, Carol A.Ytterberg, Steven R.Mortezavi, Mahta2023-11-132023-11-132023Therapeutic Advances in Musculoskeletal Disease. -15 (2023), p. 1-14. -Ther. Adv. Musculoskelet. Dis. - 1759-720X. - 1759-72181759-72181759-720Xhttps://hdl.handle.net/2437/360541Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillancefolyóiratcikkopen access journalhttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM116048OrvostudományokKlinikai orvostudományokszerző2023-11-1300109953400000185176459124